Mass General Brigham Ventures logo

Mass General Brigham Ventures

North America, Massachusetts, United States, Cambridge

Description

Mass General Brigham Ventures is the venture capital arm of Mass General Brigham that invests in early-stage companies.

Investor Profile

Mass General Brigham Ventures has made 32 investments, with 3 in the past 12 months and 13% as lead.

Stage Focus

  • Series A (41%)
  • Series B (31%)
  • Seed (19%)
  • Series C (9%)

Country Focus

  • United States (94%)
  • France (6%)

Industry Focus

  • Health Care
  • Biotechnology
  • Therapeutics
  • Medical
  • Pharmaceutical
  • Life Science
  • Wellness
  • Mental Health
  • Hospital
  • Precision Medicine
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Mass General Brigham Ventures frequently co-invest with?

OrbiMed
North America, New York, United States, New York
Co-Investments: 4
Sectoral Asset Management
North America, Quebec, Canada, Montréal
Co-Investments: 4
Alexandria Venture Investments
North America, California, United States, Pasadena
Co-Investments: 5
Google Ventures
North America, California, United States, Mountain View
Co-Investments: 5
Casdin Capital
North America, New York, United States, New York
Co-Investments: 4
RA Capital Management
North America, Massachusetts, United States, Boston
Co-Investments: 5
F-Prime Capital
North America, Massachusetts, United States, Cambridge
Co-Investments: 4
Pontifax
Asia, Tel Aviv, Israel, Herzliya
Co-Investments: 5
Sanofi Ventures
North America, Massachusetts, United States, Cambridge
Co-Investments: 5
ARCH Venture Partners
North America, Illinois, United States, Chicago
Co-Investments: 4

What are some of recent deals done by Mass General Brigham Ventures?

Abcuro

Newton, Massachusetts, United States

Abcuro develops immunotherapies to treat autoimmunity and cancer.

BiotechnologyHealth CareMedicalTherapeutics
Series CFeb 12, 2025
Amount Raised: $200,000,000
Rippl Care

Seattle, Washington, United States

Rippl Care is a mental health company committed to assisting seniors who suffer from dementia and other neurocognitive disorders.

Elder CareHealth CareHealth DiagnosticsMental Health
Series AOct 2, 2024
Amount Raised: $23,000,000
Tuesday Health

Nashville, Tennessee, United States

Tuesday Health empowers lives through supportive care by easing the symptoms and stress of serious illness.

Health CareHospitalWellness
Series AMay 21, 2024
Amount Raised: $60,000,000
InStride Health

Boston, Massachusetts, United States

InStride Health provides evidence-based OCD and anxiety treatment to keep kids and teenagers engaged along the way.

Health CareMental HealthWellness
Series BMar 27, 2024
Amount Raised: $30,000,000
Nocion Therapeutics

Cambridge, Massachusetts, United States

Nocion Therapeutics is a developer of novel pharmaceuticals intended to treat the conditions arising from neurogenic inflammation.

BiotechnologyHealth CareMedical
Series BMar 4, 2024
Amount Raised: $62,000,000
Claris Biotherapeutics

Jersey City, New Jersey, United States

Claris Biotherapeutics develops a topical formulation intended to cure corneal wounds, ulcers, and scars.

BiotechnologyHealth CareTherapeutics
Series AJan 4, 2024
Amount Raised: $57,000,000
ROME Therapeutics

Cambridge, Massachusetts, United States

ROME Therapeutics is developing novel therapies for cancer and autoimmune diseases by harnessing the power of the repeatome.

BiotechnologyHealth CarePharmaceutical
Series BSep 12, 2023
Amount Raised: $72,000,000
Abcuro

Newton, Massachusetts, United States

Abcuro develops immunotherapies to treat autoimmunity and cancer.

BiotechnologyHealth CareMedicalTherapeutics
Series BAug 17, 2023
Amount Raised: $155,000,000
Violet Therapeutics

Cambridge, Massachusetts, United States

Violet Therapeutics is a pre-clinical stage company leveraging first-in-class platforms to identify, map, and mine the cellular connectome.

Health CareMedicalTherapeutics
SeedMay 5, 2023
Amount Raised: $10,600,000
Mediar Therapeutics

Cambridge, Massachusetts, United States

Mediar is a pre-clinical stage biotechnology company developing therapeutics for the treatment of fibrosis.

BiotechnologyHealth CareMedicalTherapeutics
Series AMar 15, 2023
Amount Raised: $85,000,000